PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer
Clinical trial NCT02331927 · UNKNOWN
Trial details
- NCT number
- NCT02331927
- Sponsor
- University of Ulm
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.